NASDAQ:HTBX
Delisted
Heat Biologics Stock Price (Quote)
$2.38
+0 (+0%)
At Close: Aug 17, 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.25 | $2.84 | Wednesday, 17th Aug 2022 HTBX stock ended at $2.38. During the day the stock fluctuated 0% from a day low at $2.38 to a day high of $2.38. |
| 90 days | $1.94 | $3.15 | |
| 52 weeks | $1.94 | $7.63 |
Historical Heat Biologics prices
| Date | Open | High | Low | Close | Volume |
| 2022-08-17 | $2.38 | $2.38 | $2.38 | $2.38 | 0 |
| 2022-08-16 | $2.41 | $2.41 | $2.34 | $2.38 | 0 |
| 2022-08-15 | $2.35 | $2.48 | $2.35 | $2.39 | 0 |
| 2022-08-12 | $2.51 | $2.51 | $2.33 | $2.37 | 0 |
| 2022-08-11 | $2.70 | $2.71 | $2.52 | $2.55 | 0 |
| 2022-08-10 | $2.74 | $2.79 | $2.61 | $2.70 | 0 |
| 2022-08-09 | $2.75 | $2.84 | $2.67 | $2.72 | 0 |
| 2022-08-08 | $2.78 | $2.79 | $2.71 | $2.76 | 0 |
| 2022-08-05 | $2.64 | $2.73 | $2.59 | $2.72 | 0 |
| 2022-08-04 | $2.45 | $2.61 | $2.38 | $2.59 | 0 |
| 2022-08-03 | $2.38 | $2.46 | $2.37 | $2.45 | 0 |
| 2022-08-02 | $2.29 | $2.29 | $2.29 | $2.29 | 0 |
| 2022-08-01 | $2.32 | $2.37 | $2.27 | $2.29 | 0 |
| 2022-07-29 | $2.33 | $2.41 | $2.27 | $2.34 | 0 |
| 2022-07-28 | $2.34 | $2.49 | $2.34 | $2.38 | 0 |
| 2022-07-27 | $2.47 | $2.47 | $2.25 | $2.34 | 0 |
| 2022-07-26 | $2.51 | $2.53 | $2.48 | $2.49 | 0 |
| 2022-07-25 | $2.56 | $2.57 | $2.51 | $2.55 | 0 |
| 2022-07-22 | $2.60 | $2.60 | $2.52 | $2.52 | 0 |
| 2022-07-21 | $2.52 | $2.64 | $2.49 | $2.57 | 0 |
| 2022-07-20 | $2.56 | $2.73 | $2.56 | $2.68 | 0 |
| 2022-07-19 | $2.68 | $2.78 | $2.58 | $2.69 | 0 |
| 2022-07-18 | $2.66 | $2.78 | $2.58 | $2.64 | 0 |
| 2022-07-15 | $2.86 | $2.86 | $2.65 | $2.65 | 0 |
| 2022-07-14 | $2.75 | $2.90 | $2.75 | $2.88 | 0 |
About Heat Biologics
Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against sp... HTBX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
